Form 4: Twist BioScience COO Sells Shares for Tax Obligations

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 206 shares of common stock to cover tax withholding obligations related to Restricted Stock Units.

Summary

• Patrick John Finn, President and COO of Twist Bioscience Corp (TWST), reported a transaction on October 2, 2025.
• He sold 206 shares of common stock at a price of $29.161 per share.
• The sale was mandated to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• This was a "sell to cover" transaction and does not represent a discretionary trade by Mr. Finn.
• Following the transaction, Mr. Finn beneficially owns 232,482 shares of common stock.
• The reported beneficial ownership balance was adjusted to correct an administrative error.

Sentiment

Score: 5

Explanation: The transaction is neutral as it is a non-discretionary sale to cover tax obligations, not a reflection of management's view on the company's prospects. The administrative error correction is also neutral.

Positives

• The transaction is a non-discretionary "sell to cover" for tax obligations, indicating no negative discretionary selling intent from management.

Negatives

• A reduction in direct beneficial ownership, albeit for tax purposes, slightly decreases the insider's direct stake.

Future Outlook

The filing does not provide any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction common across publicly traded companies where executives receive equity compensation (RSUs) and are required to sell shares to cover tax liabilities upon vesting. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Minimal impact on shareholders as it is a routine, non-discretionary transaction for tax purposes and involves a small number of shares relative to the total outstanding.

Key Dates

Recommendation

The transaction is a mandatory 'sell to cover' for tax purposes, not a discretionary sale based on insider sentiment. Therefore, it provides no new fundamental information to alter an investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Twist Bioscience, TWST, Form 4, Insider Transaction, Stock Sale, Patrick John Finn, Restricted Stock Units, Tax Withholding, Sell to Cover, Corporate Officer